Literature DB >> 11717639

In vitro sealing of punctured fetal membranes: potential treatment for midtrimester premature rupture of membranes.

U M Reddy1, S S Shah, R L Nemiroff, S K Ballas, T Hyslop, J Chen, R J Wapner, A C Sciscione.   

Abstract

OBJECTIVE: Midtrimester premature rupture of membranes causes significant perinatal morbidity and death. No effective treatment exists. We investigated (1) whether a needle puncture in the fetal membranes could be sealed in vitro and (2) the optimal composition of the sealant to be used. STUDY
DESIGN: Membranes from second trimester pregnancies (16-24 weeks of gestation) were stretched over a modified syringe with a 2.5-cm open diameter. The syringe was filled with 20 mL of second trimester amniotic fluid, and the membrane was punctured with a 20-gauge needle. Sealants were injected into the amniotic fluid. The primary outcome variable was time for leakage of amniotic fluid. Median times for leakage for the formulations were compared by Wilcoxon exact rank sum test.
RESULTS: Platelets alone failed to seal the puncture site. All other formulations stopped leakage temporarily. Tisseel (Baxter Corp, Glendale, Calif) and cryoprecipitate/thrombin preparations led to more prolonged sealing of punctured amniotic membranes than platelets (P <.01) and were not significantly different from each other.
CONCLUSION: Of the sealants tested in vitro, amniotic membranes are best sealed by a fibrin/thrombin-based sealant.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717639     DOI: 10.1067/mob.2001.117685

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  Fetal membrane healing after spontaneous and iatrogenic membrane rupture: a review of current evidence.

Authors:  R Devlieger; L K Millar; G Bryant-Greenwood; L Lewi; J A Deprest
Journal:  Am J Obstet Gynecol       Date:  2006-05-08       Impact factor: 8.661

2.  Contemporary diagnosis and management of preterm premature rupture of membranes.

Authors:  Aaron B Caughey; Julian N Robinson; Errol R Norwitz
Journal:  Rev Obstet Gynecol       Date:  2008

3.  Injectable candidate sealants for fetal membrane repair: bonding and toxicity in vitro.

Authors:  Grozdana Bilic; Carrie Brubaker; Phillip B Messersmith; Ajit S Mallik; Thomas M Quinn; Claudia Haller; Elisa Done; Leonardo Gucciardo; Steffen M Zeisberger; Roland Zimmermann; Jan Deprest; Andreas H Zisch
Journal:  Am J Obstet Gynecol       Date:  2010-01       Impact factor: 8.661

4.  Cryopreserved human amniotic membrane and a bioinspired underwater adhesive to seal and promote healing of iatrogenic fetal membrane defect sites.

Authors:  R Papanna; L K Mann; S C G Tseng; R J Stewart; S S Kaur; M M Swindle; T R Kyriakides; N Tatevian; K J Moise
Journal:  Placenta       Date:  2015-05-30       Impact factor: 3.481

Review 5.  Application of Tissue Engineering and Regenerative Medicine in Prelabor Rupture of Membranes: a Review of the Current Evidence.

Authors:  Young Mi Jung; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun; Seung Mi Lee
Journal:  Reprod Sci       Date:  2021-04-13       Impact factor: 3.060

6.  Trauma induces overexpression of Cx43 in human fetal membrane defects.

Authors:  David W Barrett; Aumie Kethees; Christopher Thrasivoulou; Alvaro Mata; Alex Virasami; Neil J Sebire; Alex C Engels; Jan A Deprest; David L Becker; Anna L David; Tina T Chowdhury
Journal:  Prenat Diagn       Date:  2017-08-01       Impact factor: 3.050

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.